Angiotensin II blockade during combined thiazide-β-blocker treatment

References

• Amery A., Billiet L., Boel A., Fagard R., Reybrouck T., Willems J. Mechanism of hypotensive effect during beta-adrenergic blockade in hypertensive patients. Am. Heart J. 1976; 91: 634
   PubMed Web of Science ®Google Scholar
• Bahr C., von Coliste P., Frisk-Holmberg M., Haglund K., Jorfelt L., Orme M., Östman J., Sjöqvist F. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. Clin. Pharmac. Ther. 1976; 20: 130
   PubMedGoogle Scholar
• Beretta-Piccoli C., Weidmann P., De Chatel R., Hirsch D., Reubi F. C. Beziehungen zwischen Blutdruck, Blutvolumen und Plasmarenin während Diuretikatherapie beiessentiellerhypertonie. Schweiz. med. Wschr. 1977; 107: 104
   PubMedGoogle Scholar
• Bravo E. L., Tarazi R. C., Dustan H. P. β-adrenergic blockade in diuretic-treated patients with essential hypertension. New Engl. J. Med. 1975; 292: 66
   PubMed Web of Science ®Google Scholar
• Bravo E. L., Tarazi R. C., Dustan H. P., Lewis J. W. Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension. Circ. Res. 1975; 36 and 37: 241, Suppl I
   Google Scholar
• Bühler F. R., Laragh J. H., Baer L., Vaughan E. D., Brunner H. R. Propranolol inhibition of renin secretion. New Engl. J. Med. 1972; 287: 1209
   PubMed Web of Science ®Google Scholar
• Castenfors J., Johnsson H., Orö L. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta med. scand. 1973; 193: 189
   PubMed Web of Science ®Google Scholar
• Christensen N. J. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin. Sci. molec. Med. 1973; 45: 163
   PubMedGoogle Scholar
• Christensen N. J., Trap-Jensen J., Clausen J. P., Noer I., Krogsgaard A. R., Larsen O. A. Effect of beta-receptor blockade on heart rate, hepatic blood flow and circulating noradrenaline during exercise in man. Acta Physiol. 1975; 95: 62A
   Google Scholar
• Geyskes G. G., Boer P., Vos J., Mess E. J.D. Change in renin dependency of blood pressure induced by volume depletion and/or piopranolol therapy in hypertensive patients. Clin. Sci. molec. Med. 1976; 51: 189s
   PubMedGoogle Scholar
• Geyskes G. G., Boer P., Vos J., Leenen F. H.H., Mees E. J.D. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. Circ. Res. 1975; 36 and 37: 248, Suppl I
   Google Scholar
• Giese J., Jørgensen M., Nielsen M. D., Lund J. O., Munck O. Plasma renin concentration measured by use of radioimmunoassay for angiotensin I. Scand. J. clin. Lab. Invest. 1970; 26: 355
   PubMed Web of Science ®Google Scholar
• Hansson B.-G., Dymling J.-F., Hedeland H., Hulthen U. L. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. Eur. J. clin. Pharmac. 1977; 11: 239
   PubMedGoogle Scholar
• Hansson L. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on haemody-namic parameters and plasma renin activity. Acta med. scand. 1973; 550: 1, suppl.
   Google Scholar
• Hollifield J. W., Sherman K., Zwagg R. V., Shand D. G. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. New Engl. J. Med. 1976; 295: 68
   PubMed Web of Science ®Google Scholar
• Ibsen H., Christensen N. J., Hollnagel H., Leth A., Kappelgaard A. M., Giese J. Plasma noradrenaline concentration in hypertensive and normo-tensive forty-year-old individuals. Relationship to plasma renin concentration. Clin. Sci. molec. Med., in press
   Google Scholar
• Ibsen H., Kappelgaard A. M., Nielsen M. D., Giese J. The effect of angiotensin II blockade by saralasin (1-Sar-8-ala-angiotensin II) in normal man. Eur. J. clin. Pharmac. 1978; 14: 171
   PubMedGoogle Scholar
• Ibsen H., Leth A., Hollnagel H., Kappelgaard A. M., Nielsen M. D., Christensen N. J., Giese J. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients. Acta med. Scand. 1979; 205: 547
   PubMed Web of Science ®Google Scholar
• Ibsen H., Sederberg-Olsen P. Changes in glo-merular filtration rate during long-term treatment with propranolol in patients with essential hypertension. Clin. Sci. molec. Med. 1973; 44: 129
   Google Scholar
• Imbs J. L., Schmidt M., Velly J., Schwartz J. Comparison of the effect of two groups of diuretics on renin secretion in the anaesthetized dog. Clin. Sci. molec. Med. 1977; 52: 171
   PubMedGoogle Scholar
• Kappelgaard A. M., Nielsen M. D., Giese J. Measurement of angiotensin II in human plasma: Technical modifications and practical experience. Clinica chim. Acta. 1976; 67: 299
   PubMed Web of Science ®Google Scholar
• Karlberg B. E., Tolagen K. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension. Am. J. Med. 1976; 60: 891
   PubMed Web of Science ®Google Scholar
• Leonetti G., Mayer G., Morganti A., Terzoli L., Zanchetti A., Bianchetti G., Di Salle E., Morselli P. L., Chidsey C. A. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin. Sci. molec. Med. 1975; 48: 491
   Google Scholar
• Leth A. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide. Circulation 1970; 42: 479
   PubMed Web of Science ®Google Scholar
• Lewis P. The essential action of propranolol in hypertension. Am. J. Med. 1976; 60: 837
   PubMed Web of Science ®Google Scholar
• Michelakis A. M., McAllister R. G. The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J. clin. Endocr. 1972; 34: 386
   PubMed Web of Science ®Google Scholar
• Nielsen I., Steiness E., Hesse B. Acute and long-term salt depletion and β-blockade: Plasma renin activity response and its relation to blood pressure reduction in long-term treatment. Acta med. Scand. 1978; 203: 415
   PubMedGoogle Scholar
• Pettinger W. A., Mitchell H. C. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. New Engl. J. Med. 1975; 292: 1214
   PubMed Web of Science ®Google Scholar
• Rasmussen S., Rasmussen K. Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension. Eur. J. clin. Pharmac. 1979; 15: 305
   PubMed Web of Science ®Google Scholar
• Sweet C. S., Mandradjieff M. Enhancement of the antihypertensive effect of hydrochlorothiazide in dogs after suppression of renin release by beta-adrenergic blockade. Clin. Sci. molec. Med. 1975; 48: 147
   PubMedGoogle Scholar
• Tarazi R. C., Frohlich E. D., Dustan H. P. Plasma volume changes with long-term beta-adrenergic blockade. Am. Heart J. 1971; 82: 770
   PubMed Web of Science ®Google Scholar
• Vaughan E. D., Carey R. M., Peach M. J., Ackerly J. A., Ayers C. R. The renin response to diuretic therapy. A limitation of antihypertensive potential. Circ. Res. 1978; 42: 376
   PubMed Web of Science ®Google Scholar